Effects of Denosumab Therapy for Japanese

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, the investigators would like to analyze the bone mineral density (BMD) , bone turnover makers, and fracture prevention effects of denosumab in Japanese patients under clinical practice. The participants are treated in the investigators hospital, who are under severe osteoporotic condition.

The main objective of this study is to investigate effects of denosumab. The researchers also investigate the effects of Effects of previous osteoporotic therapy to denosumab treatment. In this study, the investigators analyse the determinants of subsequent BMD increase and fracture preventing effect by teriparatide.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tomidahama Hospital
• Treatments: Denosumab

Criteria

Inclusion Criteria:

• Osteoporotic patients

Exclusion Criteria:

• cancer, hypercalcemia, etc (i.e. patients who could not use denosumab)